Medigus Ltd. (NASDAQ:MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced its board of directors authorized the company to take actions to promote a $2 million buyback program for the company’s ADRs. The company expects to formally approve the buyback in conjunction with the approval of its financial statements for the 6 months ended June 30, 2021, and based on a financial advisor’s opinion to be obtained. The company is required to file a motion seeking a court approval for the buyback program, and the effectiveness of the buyback plan, if formally approved, will be contingent upon such court’s approval.
William Blair Initiates Coverage On CVRx with Outperform Rating
William Blair analyst Margaret Kaczor initiates coverage on CVRx (NASDAQ:CVRX) with a Outperform rating.
